Barclays lowered the firm’s price target on Pilgrim’s Pride to $28 from $29 and keeps an Overweight rating on the shares. The analyst believes Q1 marked the turning point for chicken in the U.S. While the recovery is slower than initially anticipated, Pilgrim’s remains the "single best pick to get involved in the broader protein space in the Americas," the analyst tells investors in a research note.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on PPC:
- Pilgrim’s Pride reports Q1 EPS 8c, consensus 6c
- Pilgrim’s Pride Reports First Quarter 2023 Results with $4.2 Billion in Net Sales and Operating Income of $31.3 Million
- Pilgrim’s Pride reinstated with a Market Perform at BMO Capital
- Pilgrim’s Pride Corporation to Host First Quarter Earnings Call on April 27, 2023